eli lilly retatrutide study just released impressive results for retatrutide, an investigational weight loss drug that targets three hormones—and may deliver more weight loss than current GLP-1s. See link below ⬇️ retatrutide clinical study Eli Lilly

Every order gives you the chance to enter our Transformation Challenge and win your share of 7,000 every 2 months: 4 Winners: 1,000 cash each 6 Runners up: 500 cash each Grand finale prize: 10,000 cash Your order includes an exclusive I AM IN poster, perfect for capturing your before photo and marking the start of your New You journey

This finding is sometimes cited to justify ipamorelin use in corticosteroid contexts, but that extrapolation is not supported by available evidence

Changes in HbA1c throughout the study were also not associated with reduced MACE.24 Additionally, the multiple pleiotropic effects of SEMA on metabolic, hepatic and renal function may indirectly contribute to cardiovascular protection.25 The HFpEF programme shows significant symptomatic improvement of heart failure symptoms with preserved ejection fraction (HFpEF) in obese patients treated with SEMA 2.4 mg26 (Fig

Two things that we know of as of right now